Palforzia Level 10 Capsules

Manufacturer GREER LABORATORIES Active Ingredient Peanut Allergen Powder(pee nut AL er jen pow der) Pronunciation PAL-for-zee-uh (Peanut AL-er-jen POW-der)
WARNING: Allergic reactions have happened with this drug. Rarely, some reactions can be very bad or life-threatening. Talk with the doctor.The first dose and all dose increases will be given in a doctor's office or other healthcare setting.Your doctor will give you another drug (epinephrine) to use in case of an allergic reaction. Someone else may have to give you the shot. Be sure you and other people who may need to give the shot know how and when to use it. Certain drugs may make epinephrine not work as well or raise the chance of side effects. This includes some drugs used to treat depression, heart problems, or high blood pressure. There are many drugs that interact with epinephrine. Talk with your doctor or pharmacist to make sure it is safe to take epinephrine with all of your drugs.Do not take this drug if you have very bad asthma or asthma that is not controlled. @ COMMON USES: It is used to help with allergies caused by peanuts. This drug is not for use to treat an allergic reaction.
🏷️
Drug Class
Allergen immunotherapy
🧬
Pharmacologic Class
Allergen extract
🀰
Pregnancy Category
Not assigned (Risk Summary available)
βœ…
FDA Approved
Jan 2020
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Palforzia is a medicine used to help reduce the severity of allergic reactions, including life-threatening ones, that can happen if someone with a peanut allergy accidentally eats peanuts. It works by giving you tiny, increasing amounts of peanut protein over time to help your body get used to it. It's not a cure for peanut allergy, and you still need to avoid peanuts and carry an epinephrine auto-injector.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To ensure you get the most benefit from your medication, follow these steps:

1. Follow Your Doctor's Orders: Take this medication exactly as directed by your doctor. Read all the information provided to you and follow the instructions carefully.
2. Take with Food: Take your medication with a meal to help your body absorb it properly.
3. Consistent Schedule: Take your medication at the same time every day. It is recommended to take it in the evening.
4. Preparing Your Dose: Do not swallow the capsules or inhale the powder. Instead, open the capsule or sachet and mix the contents with a few spoonfuls of soft food, such as applesauce, yogurt, or pudding. Mix well to ensure the medication is evenly distributed. Do not mix with liquids.
5. Take Immediately: After mixing, take your dose right away. Do not store the mixture for future use.
6. Continue as Directed: Keep taking your medication as instructed by your doctor or healthcare provider, even if you start to feel well.
7. Dispose of Leftovers: Throw away any remaining medication after you have taken your dose.
8. Hand Hygiene: Wash your hands after handling the medication.
9. Special Instructions for Doctor's Visits: If you are visiting your doctor for a dose increase, do not take your medication on that day.

Storing and Disposing of Your Medication

Store your medication in a refrigerator or at room temperature.
If you miss a dose, call your doctor to find out what to do.
πŸ’‘

Lifestyle & Tips

  • Strictly avoid peanuts in your diet, even while on Palforzia.
  • Always carry at least two epinephrine auto-injectors and know how to use them.
  • Administer daily doses consistently at home, preferably with food, and never increase your dose on your own.
  • Report any allergic reactions or worsening asthma symptoms to your healthcare provider immediately.
  • Attend all scheduled appointments for dose escalation and monitoring in the healthcare setting.
  • Do not take Palforzia if you have uncontrolled asthma or eosinophilic esophagitis.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 300 mg daily (maintenance dose)

Condition-Specific Dosing:

Peanut Allergy (Maintenance): After completing Initial Dose Escalation and Up-Dosing phases, patients take 300 mg (Level 10) daily. The first dose of each Up-Dosing level and the first dose of the Initial Dose Escalation must be administered in a healthcare setting.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Approved for ages 4-17 years. Dosing regimen is identical to adult dosing, starting with Initial Dose Escalation, followed by Up-Dosing (11 levels, including Level 10 which is 300 mg), and then daily maintenance of 300 mg.
Adolescent: Approved for ages 4-17 years. Dosing regimen is identical to adult dosing, starting with Initial Dose Escalation, followed by Up-Dosing (11 levels, including Level 10 which is 300 mg), and then daily maintenance of 300 mg.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment recommended
Moderate: No specific adjustment recommended
Severe: No specific adjustment recommended
Dialysis: No specific adjustment recommended

Hepatic Impairment:

Mild: No specific adjustment recommended
Moderate: No specific adjustment recommended
Severe: No specific adjustment recommended

Pharmacology

πŸ”¬

Mechanism of Action

Palforzia is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut. It works by inducing desensitization to peanut allergens through repeated, controlled exposure to increasing amounts of peanut protein. This process is thought to modulate the immune response, shifting it from a Th2-mediated allergic response (characterized by IgE production and mast cell/basophil activation) towards a more Th1-mediated response, increasing IgG4 antibodies, and potentially inducing T-regulatory cells, thereby reducing the severity of allergic reactions upon subsequent accidental peanut exposure.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Not applicable (allergen, not systemically absorbed in typical drug sense)
Tmax: Not applicable
FoodEffect: Administered with food to reduce gastrointestinal symptoms

Distribution:

Vd: Not applicable
ProteinBinding: Not applicable
CnssPenetration: No

Elimination:

HalfLife: Not applicable
Clearance: Not applicable
ExcretionRoute: Not applicable
Unchanged: Not applicable
⏱️

Pharmacodynamics

OnsetOfAction: Gradual, over weeks to months of treatment
PeakEffect: Achieved after reaching and maintaining the 300 mg daily dose
DurationOfAction: Ongoing with continued daily maintenance therapy
Confidence: High

Safety & Warnings

⚠️

BLACK BOX WARNING

WARNING: RISK OF ANAPHYLAXIS
PALFORZIA can cause anaphylaxis, which may be life-threatening. PALFORZIA is available only through a restricted program called the PALFORZIA Risk Evaluation and Mitigation Strategy (REMS) Program. PALFORZIA must be administered in a healthcare setting equipped to manage anaphylaxis, and patients must be observed for at least 60 minutes following administration. Patients must have injectable epinephrine available for immediate use at all times. Do not administer PALFORZIA to patients with uncontrolled asthma. See full prescribing information for complete Boxed Warning.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you or your child experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Trouble swallowing or speaking
Pain when swallowing
Heartburn
Chest pain or pressure
Fast heartbeat
Passing out
Dizziness
Flushing
Shortness of breath
Severe diarrhea
Stomach cramps

In children, watch for:
Unusual crying
Feeling sluggish or extremely sleepy
Pulling legs up to the stomach

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you or your child experience any of the following side effects, contact your doctor for advice:

Diarrhea
Stomach pain
Upset stomach
Vomiting
Itching in the ear, mouth, or tongue
Numbness or tingling in the mouth
Throat irritation
Cough
Runny or stuffy nose
* Sneezing

This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Difficulty breathing, wheezing, shortness of breath
  • Hives, rash, itching, swelling (especially of face, lips, tongue, throat)
  • Dizziness, lightheadedness, fainting
  • Rapid or weak pulse
  • Severe abdominal pain, vomiting, diarrhea
  • Feeling of impending doom
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
A history of life-threatening reactions to peanuts.
Previous severe allergic reactions.
Eosinophilic esophagitis or other eosinophilic stomach or bowel diseases.
* Heart problems, lung problems, or mast cell disorders.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Adhere to the diet plan recommended by your doctor and continue to avoid peanuts as previously advised.

Certain conditions or activities may increase your risk of an allergic reaction. Therefore, discuss the following with your doctor: alcohol consumption, illness such as viral infections, fasting, fatigue or lack of sleep, menstrual periods, or the use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen.

To minimize potential risks, do not take this medication within 3 hours before or after exercising or taking a hot shower or bath. If you have recently exercised or taken a hot shower or bath and are experiencing symptoms such as feeling hot, sweating, or rapid breathing or heartbeat, wait until these symptoms resolve before taking your medication.

If you have asthma and experience difficulty breathing or a worsening of your asthma symptoms, contact your doctor immediately.

It is crucial to discuss your pregnancy status or plans with your doctor, as well as any breast-feeding intentions. This will enable a thorough discussion about the benefits and risks of this medication to both you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Severe allergic reaction, including anaphylaxis

What to Do:

Seek immediate medical attention. Administer epinephrine if signs of anaphylaxis are present. Call 911 or your local emergency number. Call 1-800-222-1222 for Poison Control.

Drug Interactions

🚫

Contraindicated Interactions

  • Uncontrolled asthma
  • Eosinophilic esophagitis or other eosinophilic gastrointestinal disease
  • Known hypersensitivity to any Palforzia excipients
πŸ”΄

Major Interactions

  • Beta-blockers (may exacerbate anaphylaxis and interfere with epinephrine treatment)
  • Angiotensin-converting enzyme (ACE) inhibitors (may increase risk of anaphylaxis)
  • Antihistamines (may mask symptoms of allergic reaction, but may be used for symptom management)
  • Omalizumab (Xolair) - concurrent use has not been studied, potential for altered immune response
🟑

Moderate Interactions

  • Systemic corticosteroids (may suppress immune response, potentially affecting efficacy)
  • Immunosuppressants (may suppress immune response, potentially affecting efficacy)

Monitoring

πŸ”¬

Baseline Monitoring

Confirmed diagnosis of peanut allergy

Rationale: Essential for appropriate patient selection

Timing: Prior to initiation

Asthma control assessment (e.g., spirometry, FEV1)

Rationale: Uncontrolled asthma is a contraindication; well-controlled asthma is required

Timing: Prior to initiation and periodically

Eosinophilic esophagitis screening (history of dysphagia, reflux)

Rationale: Eosinophilic esophagitis is a contraindication

Timing: Prior to initiation

Patient and caregiver education on anaphylaxis recognition and epinephrine auto-injector use

Rationale: Crucial for patient safety and management of potential reactions

Timing: Prior to initiation

πŸ“Š

Routine Monitoring

Observation for allergic reactions (e.g., anaphylaxis, GI symptoms, respiratory symptoms, skin reactions)

Frequency: During and after each dose in the healthcare setting (Initial Dose Escalation, first dose of each Up-Dosing level); daily by patient/caregiver for home doses

Target: Absence of severe reactions

Action Threshold: Any signs of allergic reaction require immediate assessment and potential treatment (e.g., epinephrine)

Asthma control

Frequency: Regularly throughout treatment

Target: Well-controlled asthma

Action Threshold: Worsening asthma control may require temporary interruption or discontinuation of Palforzia

Adherence to daily dosing

Frequency: Regularly

Target: Consistent daily dosing

Action Threshold: Missed doses may require re-evaluation and potential re-initiation at a lower dose

πŸ‘οΈ

Symptom Monitoring

  • Anaphylaxis (difficulty breathing, wheezing, hives, swelling, dizziness, rapid heart rate, severe abdominal pain, vomiting, diarrhea, feeling of impending doom)
  • Gastrointestinal symptoms (abdominal pain, nausea, vomiting, diarrhea)
  • Respiratory symptoms (cough, shortness of breath, wheezing, chest tightness)
  • Skin reactions (hives, itching, flushing, angioedema)
  • Oral symptoms (oral itching, tingling, swelling of lips/tongue/throat)

Special Patient Groups

🀰

Pregnancy

There are no adequate and well-controlled studies of Palforzia in pregnant women. Animal reproduction studies have not been conducted. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. The clinical significance of IgE-mediated allergic reactions in pregnant women is unknown.

Trimester-Specific Risks:

First Trimester: Unknown
Second Trimester: Unknown
Third Trimester: Unknown
🀱

Lactation

There are no data on the presence of peanut allergen in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Palforzia and any potential adverse effects on the breastfed infant from Palforzia or from the underlying maternal condition.

Infant Risk: Unknown
πŸ‘Ά

Pediatric Use

Approved for patients aged 4 through 17 years. Safety and effectiveness have not been established in patients younger than 4 years of age. The dosing regimen is the same as for adults.

πŸ‘΄

Geriatric Use

Clinical studies of Palforzia did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Palforzia is not typically used in this population.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Palforzia is NOT a cure for peanut allergy; patients must continue strict peanut avoidance and carry epinephrine.
  • The first dose of Initial Dose Escalation and the first dose of each Up-Dosing level MUST be administered in a healthcare setting with anaphylaxis management capabilities.
  • Patients must be observed for at least 60 minutes after administration of doses in the healthcare setting.
  • Missed doses or prolonged interruptions in treatment may require re-initiation at a lower dose under medical supervision.
  • Patients should take Palforzia with food to help mitigate gastrointestinal symptoms.
  • Uncontrolled asthma and eosinophilic esophagitis are absolute contraindications.
πŸ”„

Alternative Therapies

  • Strict peanut avoidance (standard of care prior to OIT)
  • Epinephrine auto-injectors (for emergency treatment of allergic reactions)
  • Antihistamines (for symptomatic relief of mild allergic reactions)
  • Corticosteroids (for severe allergic reactions)
  • Omalizumab (Xolair) - an anti-IgE antibody, not approved for peanut allergy but used off-label in some cases or in clinical trials for food allergy.
πŸ’°

Cost & Coverage

Average Cost: Varies significantly, often several thousand dollars per month per month
Insurance Coverage: Specialty Tier (requires prior authorization, step therapy, and/or quantity limits)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a valuable resource that provides important information about your treatment. Please read this guide carefully and review it again whenever you receive a refill of your medication. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, pharmacist, or other healthcare provider for clarification.

In the event of a suspected overdose, it's crucial to seek immediate medical attention. Call your local poison control center or visit the emergency room right away. When seeking help, be prepared to provide detailed information about the overdose, including the type and amount of medication taken, as well as the time it was taken.